GlassScriptPhysician profile
Marko A Lekovic
NPI 1689739781
$1,609.53
in general payments reported to CMS, 2019-2025
23 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $266 · 2021: $317 · 2022: $168 · 2023: $243 · 2024: $119 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.83 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.71 | 2019-2024 | |
| Hologic Sales and Service, LLC | $221.02 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Coolseal Generator |
| Novo Nordisk INC | $153.05 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $84.98 | 2019-2021 | |
| Boston Scientific Corporation | $78.02 | 2019-2024 | Solyx Sis System |
| Pfizer INC. | $76.72 | 2019-2023 | |
| Avion Pharmaceuticals | $63.09 | 2021-2022 | |
| Organon LLC | $61.62 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $55.49 | 2020-2022 | |
| Astellas Pharma US INC | $51.85 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $47.18 | 2019-2021 | |
| Aesculap, INC. | $40.97 | 2019 | |
| Agile Therapeutics, INC. | $37.07 | 2021 | |
| Amgen INC. | $36.30 | 2024 | Evenity, Prolia |
| Coopersurgical, INC. | $30.10 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $26.46 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $26.21 | 2020 | |
| Medicem INC. | $22.44 | 2020 | |
| Exeltis, USA INC. | $21.81 | 2023 | Slynd |
| Astrazeneca Pharmaceuticals LP | $21.52 | 2025 | Farxiga |
| Evofem Biosciences, INC. | $20.58 | 2021 | |
| Gynesonics, INC. | $20.28 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Dysis Medical, INC. | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marko Lekovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.